Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 95%
filed 2026-07-14
Item 5.02
The filing discloses the appointment of Sarah M. Romano as Chief Financial Officer, effective August 3, 2026. While the disclosure also includes compensatory arrangements (base salary of $440,000, annual bonus eligibility, and stock option grant of 750,000 shares), the principal action is the appointment of a named executive officer to a C-suite position. The appointment of a CFO is material to investors as it affects the company's financial leadership and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
PVH Corp. announced the appointment of Alexis Rollier as Chief Financial Officer, effective early September 2026, replacing interim CFO Melissa Stone. The filing discloses a detailed employment agreement with compensation terms including $850,000 base salary, bonus opportunities up to 200% of base, and equity awards totaling approximately $2.825 million in PSUs, RSUs, and sign-on awards. This is a material executive appointment to a principal officer position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-14
Item 5.02
The filing discloses the appointment of Paul Lapping as a director of Churchill Capital Corp XII effective July 13, 2026, along with his appointment to the compensation and audit committees and as audit committee chairperson. While the section also mentions director compensation agreements, the principal disclosed action is the appointment of a new director to the board and committee positions, making exec_appointment the most salient event type.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-14
Item 5.02
Domino's appointed Michael C. Creedon, Jr. (former CEO of Dollar Tree) and Anneliese Olson (former President of HP's Imaging, Printing and Solutions division) to the Board of Directors effective July 15, 2026, increasing the Board size from eight to ten directors.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-14
Vale's Board of Directors elected Mr. Wilfred Theodoor Bruijn, an independent board member, to serve as Chairman of the Board of Directors, filling a vacancy that arose on July 6, 2026. The appointment of a Chairman is a material governance event affecting the registrant's leadership structure and would influence a reasonable investor's assessment of the company's governance and direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-14
Item 5.02
The filing discloses the appointment of Michael Jennings and Zamir Rauf to the Board of Directors of the General Partner, effective July 14, 2026, with detailed descriptions of their qualifications and committee assignments. While the disclosure also includes compensatory arrangements (phantom units and cash fees) and the resignations of two directors, the principal action is the appointment of two new independent directors with substantial energy-sector experience. This is material to investors as board composition affects governance and oversight.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-14
EX-99.1
The exhibit is a press release announcing the appointment of Gadi Levin as Chief Financial Officer of A2Z Cust2Mate Solutions Corp. effective immediately. The disclosure explicitly states "Gadi Levin has been appointed Chief Financial Officer" and includes quotes from the Executive Chair endorsing his qualifications and experience. This is a clear executive appointment of a named executive officer to a material position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-14
Item 5.02
The filing discloses both a director departure (Annie Van Broekhoven's retirement and resignation from the Board effective July 8, 2026) and a director appointment (Carlo Campiciano appointed to the Board the same day). While both events occurred, the principal disclosed action centers on the appointment of Campiciano, with detailed biographical information provided about his qualifications, experience as CFO and Company Secretary of MedAdvisor Limited, and expertise in finance, taxation, and corporate governance. The appointment is the forward-looking action that fills the vacancy and is material to investors assessing board composition.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 75%
filed 2026-07-14
The 6-K discloses two material executive changes effective July 1, 2026: Mr. Hiroshi Furukawa's promotion from CEO to Chairman and CTO, and Mr. Hideaki Horikiri's promotion from CFO to President and COO. While the filing also mentions Mr. Toshihito Kanai's resignation as CTO and Director, the principal disclosed actions are the appointments/promotions of Furukawa and Horikiri to new executive roles. Both remain principal executive and financial officers respectively under SOX, making these material governance events affecting leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-14
Item 5.02
Alex Shootman was appointed to PagerDuty's Board of Directors effective July 14, 2026, and simultaneously appointed to the Audit Committee and Compensation Committee. Shootman brings 25+ years of operating experience and prior CEO roles at Workfront and Eloqua, representing a material change to the company's board composition and governance oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 88%
filed 2026-07-14
Item 5.02
Stan Guidroz was appointed Chief Operating Officer of Accel Entertainment effective July 14, 2026, representing a material appointment to a C-suite operational leadership role.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
Item 5.02
Kyle Callaway was appointed Chief Accounting Officer effective July 10, 2026, a named executive officer role. The disclosure centers on the appointment action itself—a promotion from Controller to CAO—with detailed background on his qualifications and prior experience. This is a material executive appointment that would affect investor assessment of the company's financial leadership and accounting oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
Item 5.02
The disclosure centers on the Board's appointment of Gregory L. Heston as a Class III director effective July 10, 2026, filling a vacancy created by David Kornblatt's resignation. While the resignation is mentioned, the principal action disclosed is Heston's appointment to the Board and assignment to the Audit Committee. His extensive background as a retired EY audit partner with 38 years of public accounting experience and CPA credentials makes this a material governance event affecting the registrant's board composition and audit oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-13
Item 5.02
Robert Brackenbury was appointed to the Board of Directors as a Class I director on July 9, 2026, and will serve on the audit committee. The disclosure centers on the appointment of a new director with substantial experience in investment management and governance, making this a material executive appointment under Item 5.02.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 93%
filed 2026-07-13
Item 5.02
Robin Rossmann was appointed Chief Financial Officer of CoStar Group effective July 31, 2026, succeeding Christian Lown. The appointment includes significant compensatory arrangements ($590,000 base salary, $2.5M equity grant, $500K relocation subsidy) and is material as it involves a key C-suite executive position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-13
Item 5.02
The filing discloses the appointment of Anthony Pierce as a Class III director effective immediately, approved by the Board on July 9, 2026. While the disclosure also includes compensatory details (annual cash retainer of $55,000 and equity grant of $300,000), the principal action is the appointment itself. The Board expanded the authorized number of directors from 10 to 11 specifically to accommodate this appointment, making the directorship the salient event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-13
Item 5.02
The filing discloses both the resignation of Edward M. Weil, Jr. as Chairman and director (effective July 9, 2026) and the appointment of Nicholas S. Schorsch, Jr. as Class III director and Chairman on July 10, 2026. While both events occurred, the principal action disclosed is the appointment of a new Chairman to fill the vacancy, making exec_appointment the most salient classification. Schorsch, Jr. was already serving as CEO since March 2025 and brings substantial real-estate and capital markets experience, making this a material leadership transition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-13
Item 5.02
The filing discloses the appointment of Barend (Barrie) J. van der Merwe, the current Chief Financial Officer, to the position of Chief Executive Officer effective August 1, 2026, along with his election as Managing Director of the Board. While the section also covers the departure of the interim CEO (Spindler) and appointment of an interim CFO (Deoji), the principal disclosed action centers on the appointment of a new CEO—a material executive leadership change. The detailed compensation terms and board expansion to accommodate this appointment further underscore the materiality of this executive appointment event.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 85%
filed 2026-07-13
EX-99.1
The press release announces the appointment of Dr. Jeff Millard as Executive Vice President, Technical Operations, effective July 13, 2026, and the promotion of Dr. Alex Therien to Executive Vice President, Research & Development. While the release also discloses Amanda Malone's departure as Chief Scientific and Operating Officer, the principal disclosed action is the addition of experienced executive leadership to support the company's transition to late-stage development ahead of the Q4 2026 RESOLVE trial interim release. This is material to investors assessing management capability during a critical growth phase.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-13
Item 5.02
Nickolas Stavropoulos was appointed to ONE Gas's Board of Directors on July 13, 2026, expanding the board from eight to nine members. He was assigned to three board committees (Audit, Corporate Governance, and Executive Compensation) and brings 40+ years of energy industry experience, including prior roles as COO of PG&E and National Grid.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-13
Item 5.02
The Board elected Ms. Ekta Singh-Bushell as a director effective August 1, 2026, and appointed her to the Audit Committee. This is a clear executive appointment to the Board of Directors, the principal disclosed action. While the Item 5.02(d) section also mentions compensatory arrangements (customary non-employee director compensation), the core event is the appointment itself, which is material to investors as it affects board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-13
Item 5.02
The filing discloses the appointment of John Mitchell to Energy Recovery's Board of Directors on July 9, 2026, expanding the board to six directors. This is a clear executive appointment under Item 5.02, with detailed biographical information about Mitchell's extensive leadership experience at TE Connectivity and other technology-driven companies. Board appointments are material governance events affecting investor assessment of the company's leadership and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-13
Item 5.02
The disclosure centers on the Board's appointment of Alexis N. Tirrito as interim CFO effective July 7, 2026, following Raymond S. Frech's resignation as CFO on the same day. While both a departure and appointment occur, the principal disclosed action is Tirrito's assumption of the CFO role with associated compensation adjustments ($240,000 base salary and 20% target bonus). This is material as it involves a change in principal financial officer and principal accounting officer positions at the company.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-13
The filing discloses the appointment of Brynner Chiam as Interim Co-Chief Executive Officer effective July 10, 2026, alongside existing Co-CEO Shang Ju Lin. This is a material executive appointment to a senior leadership role. Mr. Chiam, who has served as CFO and director since August 2025, will continue in those roles while assuming the interim co-CEO position, representing a significant change in the Company's leadership structure during a stated "transitional period."
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-13
Item 5.02
The Trade Desk appointed Penry Price to its board of directors effective July 9, 2026, as a Class II director with committee assignments (Audit Committee member and Compensation Committee chair). While the disclosure includes compensatory details (annual cash of $112,500 plus equity grants valued at $290,000 initial and $290,000 annual), the principal disclosed action is the appointment of a new director to the board, making this an exec_appointment event. The appointment is material as it expands the board from six to seven directors and brings an experienced advertising industry executive with deep AI expertise to the company's governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-13
Item 5.02
Michael P. Dickerson was appointed as Interim Chief Financial Officer on July 11, 2026, following Joseph Visconti's resignation from that role. Dickerson's consulting agreement was amended to provide equity grants of 3,970 RSUs and contingent cash payments tied to the merger agreement.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-13
Item 5.02
The filing discloses the appointment of two new directors—Robert Iannone, M.D., M.S.C.E. as a Class I director and Flavia Borellini, Ph.D. as a Class II director—to fill newly-created board vacancies following an increase in authorized board size from seven to nine members. Dr. Borellini was also appointed chairperson of the R&D Committee. This is a clear executive appointment event material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-13
Item 8.01
Russell Rosa was appointed Chief Revenue Officer of N-able effective immediately, with responsibility for the global sales organization, channel and partner ecosystem, support, and sales operations.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-13
Item 5.02
Klaviyo appointed Erica Smith as Chief Financial Officer effective September 1, 2026, succeeding Amanda Whalen. Smith's compensation package includes a base salary of $550,000, 50% bonus target, $15M RSU grant, and $3M PSU grant.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-13
Item 5.02
Amechi Nwachuku was appointed as Chief Operating Officer effective July 13, 2026, a senior executive position. While the disclosure includes compensatory details (base salary of $445,000, 45% target bonus, 800,000 stock options, and severance arrangements), the principal disclosed action is the appointment of a named executive to a C-suite role. This is material to investors as it signals a significant leadership change at the company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-13
Item 5.02
The Board appointed Steven Bandrowczak, a former CEO of Xerox with extensive senior leadership experience, to serve as a director effective July 13, 2026, and as a member of the audit committee. This is a clear executive appointment of a director to the Board, which is material to investors as it affects governance composition and audit oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-13
Item 5.02
The filing discloses both a board resignation (Bill Beargie on July 7, 2026) and a board appointment (Rick Keyes on July 8, 2026). While both events are present, the substantive disclosure centers on the appointment of Rick Keyes as an independent director with detailed background on his qualifications, including his role as President and CEO of Meijer, Inc. since 2017, and his service on other public company boards. The appointment is the principal forward-looking action and is material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-10
Item 5.02
O'Reilly appointed Colin Yankee as Executive Vice President and Chief Supply Chain Officer, effective July 13, 2026. While the disclosure includes compensatory details (base salary of $700,000, performance incentive target of 85%, stock option awards totaling $500,000 grant-date fair value plus annual grants), the principal disclosed action is the appointment of a named executive officer to a senior leadership position. This is a material executive appointment that would affect investor assessment of the company's leadership and operational strategy.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-10
Item 5.02
Four independent directors—Garrett Curran, Alberto Alsina Gonzalez, Matthew Murphy, and Marc Spiegel—were appointed to the board of directors on July 9, 2026 in connection with the IPO, with assignments to the Audit and Compensation committees. This material governance event establishes the company's independent board oversight structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-10
Item 5.02
The filing discloses both the resignation of two directors (William M. Goodyear and Mark McGowan) and the appointment of Maria Veltre to the Board, effective immediately on July 10, 2026. While both events are disclosed, the principal action emphasized in the Item 5.02 structure and press release is the appointment of Veltre as a new director, making this an exec_appointment event. The departures are characterized as planned and non-contentious, and the Board reduction is a routine governance adjustment. Veltre's appointment to the Board of a NYSE-listed company is material to investors.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-07-10
The 6-K discloses the appointment of Wesley Chu as an independent director, chairman of the compensation committee, and member of the audit and nominating committees, effective July 10, 2026. While the filing also mentions the concurrent resignation of Qi Ding, the principal disclosed action is Chu's appointment to the Board with specific committee assignments and compensation. The appointment is material as it affects board composition and governance structure, particularly in the context of the Company's stated intention to increase U.S.-based board representation.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-10
The 6-K discloses the election of Mr. Alessandro de Castro Melo to the position of Chief Engineering, Technology and Innovation Officer by the Board of Directors on July 10, 2026. This is a material executive appointment to a named officer position, approved by the Board following recommendation by the People and Organization Committee, with a term extending to 2028.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-10
Item 7.01
The filing discloses the appointment of Jeff Hopmayer to MDWerks' Board of Directors, effective June 26, 2026. The press release (Exhibit 99.1) emphasizes Hopmayer's appointment as a pivotal addition to the board during a critical commercial inflection point, highlighting his experience in building and scaling businesses and his role in corporate strategy, partnerships, and M&A. This is a clear executive appointment event, material to investors assessing the company's leadership and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-10
Item 5.02
The disclosure centers on the appointment of Matt Levine as Chief Legal Officer effective July 27, 2026, with detailed background on his prior roles at Clear Secure and Success Academy. While Erin Abrams's departure is also mentioned, the principal action disclosed is the appointment of a new CLO to fill this officer-level position. The appointment of a C-suite executive is material to investors assessing the company's leadership and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-10
Item 5.02
The filing discloses the appointment of Joshua Chien as an independent director of the Board, effective July 8, 2026, upon recommendation from the Nominating and Corporate Governance Committee. While the Item 5.02 section also mentions compensatory arrangements (annual cash retainer of $60,000 and restricted share unit award of $170,000), the principal disclosed action is the appointment of a director to the Board. This is material as it affects the composition and governance of the company's leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-10
Item 5.02
The filing discloses the appointment of two independent directors, Vivek Mohindra and Eiso Kant, to the Board of Directors of Axon Enterprise effective July 8, 2026, along with their committee assignments. While the disclosure also includes compensatory arrangements (RSU awards and cash retainers), the principal disclosed action centers on the appointment of these individuals to the Board and their committee roles, making exec_appointment the most salient classification. The material nature is clear given the addition of senior leadership to the Board.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-07-10
EX-99.1
The press release announces the appointment of Carl von Halem as Interim Chief Financial Officer of VERAXA Biotech AG, succeeding Torsten Bürgermeister. While the disclosure also references Bürgermeister's departure, the principal disclosed action is the appointment of a named executive to a C-suite role. The appointment of a CFO is material to investors as it affects the company's financial leadership and operational continuity, particularly given the company's recent NASDAQ listing and growth phase.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-10
Item 5.02
Neil Adler was appointed as Chief Financial Officer effective July 9, 2026, with an annual base salary of $200,000. The appointment follows the non-renewal of the employment agreement of departing CFO Neelam Patel, effective September 16, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-09
Item 5.02
The filing discloses the appointment of three officers to SoCalGas: Karen L. Sedgwick as CEO and President (effective Q3 2026), Ross W. Turrini as Chief Operating Officer (effective August 10, 2026), and Elvia Lima Ortiz as Vice President, Chief Accounting Officer and Controller (effective July 10, 2026). While the section also includes a departure (Sara P. Mijares resigning as Chief Accounting Officer) and compensation details for the new appointees, the principal disclosed actions center on the three executive appointments, particularly the CEO appointment, which is material to investors assessing leadership and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-09
Item 5.02
Frank Scognamiglio was appointed as Corporate Vice President, Chief Accounting Officer, effective July 9, 2026, succeeding Christopher Caridi as the Company's principal accounting officer. While the disclosure includes compensatory details (base salary of $340,000, target bonus of 40%, and RSU grant of $100,000), the principal disclosed action is the appointment of an officer to a key financial leadership role. The appointment of a principal accounting officer is material to investors' assessment of financial reporting governance and internal controls.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-09
Item 5.02
Central Plains Bancshares, Inc. appointed two individuals, Dannel R. Garness and Francis Younes, to the Boards of Directors of both Central Plains Bancshares, Inc. and Home Federal Savings and Loan Association of Grand Island on July 7, 2026. The appointment of Francis Younes followed an interview process initiated by activist shareholder pressure from the Stilwell Group.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-09
Item 5.02
The company appointed Giorgio Matteo Tarditi as President and Chief Operating Officer, Louis Martin as Chief Commercial Officer, and Alfredo Luchini as Chief Financial Officer, effective August 3–10, 2026, representing a significant restructuring of senior leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-09
Item 5.02
The filing discloses the Board's appointment of Justin C. Bird as Executive Vice President and Chief Financial Officer of Sempra, effective on or around the closing of the planned sale of Sempra Infrastructure Partners equity (Q3 2026). While the filing also mentions Karen L. Sedgwick's concurrent appointment as CEO and President of Southern California Gas Company, the principal disclosed action centers on Bird's appointment to the CFO role—a material executive position change at the parent company level. The appointment of a CFO with over two decades of leadership experience at Sempra is material to investors assessing the registrant's governance and financial leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-09
Item 5.02
Kristina Campbell was appointed to the Board of Directors effective July 6, 2026, as an independent director and designated as Chair of the Audit Committee. Campbell brings extensive fintech and digital asset experience from her roles as CFO at Ripple Labs, PayNearMe, and Wrapbook, and is designated as an Audit Committee Financial Expert.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-09
Item 5.02
The filing discloses the appointment of Nancy Bowman, M.D., Ph.D., as Chief Regulatory Officer effective August 3, 2026, succeeding William Turner. While Turner's transition to Special Advisor represents a departure from his CRO role, the principal disclosed action centers on the appointment of a new CRO—a material executive officer position at a therapeutic company where regulatory affairs are critical to operations and strategy.
View raw filing on EDGAR →